| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.043 | 0.3 |